The recent focus in the market revolves around
GE HealthCare Technologies Inc. (NASDAQ:GEHC), where it's clear that institutional investors own a dominant share, with percentages varying around 70%. Multiple institutions have been increasing or decreasing their holdings in the company, including MCF Advisors LLC and New England Research & Management Inc. A second quarter cash dividend for 2024 has been announced. Other occurrences include the purchase of thousands of shares by Artemis Investment Management LLP and Global Assets Advisory LLC, indicative of strong investor confidence. The company has launched efforts to enhance its capabilities, particularly in
Cardiovascular Disease workflow and
Interventional Radiology. However, their recent stock crash of 14% has raised concerns about the
viability of the investment. There are indications of an undervaluation of the company to the tune of 49%, which implies potential value for investors. On a disappointing note, its Q1 2024 returns fell below estimates marked by weakness in the China market. Despite this, experts still consider the company a good long-term investment.
Ge Healthcare Technologies GEHC News Analytics from Mon, 27 Nov 2023 08:00:00 GMT to Sun, 30 Jun 2024 11:30:19 GMT -
Rating -4
- Innovation 3
- Information 6
- Rumor -2
